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Summary
Thymocytes differentiate in the thymic microenvironment into immunocompetent T cell through
the interaction with a variety of accessory cells, including thymic epithelial cells (TEC) . TEC
play an important role in the selection process presenting self antigens in association with major
histocompatibilitycomplex(MHC) molecules to the maturingT cells . TheT cell receptor recognizes
the selfantigen-MHC complex, but other surface molecules help stabilize this interaction. Thus,
the CD2/LFA3 and LFA-1/intercellular adhesion molecule 1 pairs have been shown to participate
in the binding between lymphoid cells and TEC. Here we describe an integrin of the very late
activation antigen subfamily composed by the known Nt chain and by a novel ci chain. This
adhesion molecule is expressed on the surface of medullary TEC and is involved in the adhesion
between TEC and thymocytes, but not peripheral blood T lymphocytes.
T
he thymus provides the microenvironment for the
differentiation of immature lymphoid cells into im-
munocompetent T cells . This maturation process requires the
direct interaction between thymocytes and the nonlymphoid
compartment ofthe thymus, which is comprised ofa variety
of accessory cells, including thymic epithelial cells (TEC),'
macrophages, and interdigitating/dendritic cells (1-4) . These
cells may present antigens and secrete soluble factors (IIr1,
granulocyte/macrophage [GM]-CSF, 11,3-like activity, and
ID6) effective on the maturation ofT cells (5-8) . The acces-
sory cells are also thought to play an important role in the
selection process through which only those thymocytes un-
able to recognize self antigens and hence directed against for-
eign determinants are allowed to survive, proliferate, and leave
the thymus as mature T lymphocytes. Although the precise
role of the different accessory cells in this process is still un-
clear, it is generally agreed thatTEC are involved in the posi-
tive selection of thymocytes capable ofrecognizing selfMHC
molecules (9-11) . It has also been proposed that TEC pre-
senting self antigens in association with their MHC mole-
cules participate in the removal of self-reactive cells from the
pool of immature thymocytes (12, 13) . Such crucial mecha-
nisms require an intimate and extensive contact to ensure a
precise selection .
' Abbreviations used in this paper: APAAP, alkaline phosphatase-antialkaline
phosphatase; EGF, epidermal growth factor; GM-CSF, granulocyte/macro-
phage colony-stimulating factor; ICAM-1, intercellular adhesion molecule
1 ; PAP, peroxidase-antiperoxidase; TEC, thymic epithelial cell; VLA, very
late antigen .
Although the TCR/antigen-MHC interaction is the one
that decides the fate of the cell, its instability, even with the
contribution provided by CD4 or CD8 molecules (14-19),
makes it unlikely that it alone may be able to sustain a strong
interaction that requires an extensive cell-to-cell contact . In
this connection, it has been shown that mature T lympho-
cytes and thymocytes bind to cultured TEC via their surface
CD2 and LFA1 molecules and that their ligands are LFA3
and intercellular adhesion molecule 1 (ICAM-1), respectively
(20-22) . However, rosette formation between thymocytes and
cultured TEC is not completely inhibited by mAbs to CD2
and to LFA1 . This observation suggests that other molec-
ular interactions may participate in the binding event (21) .
In this study, we describe a novel molecule of the integrin
family, composed by the known 01 chain and by an ot chain
different from those described so far. This molecule is ex-
pressed on the surface ofepithelial cells ofthe thymic medulla,
and participates in the binding of thymocytes, but not of ma-
ture T lymphocytes, to cultured TEC .
Materials and Methods
Cells.
￿
Thymic tissue was obtained from children (aged 6 mo
to 3 yr) undergoing cardiac surgery. Thymic cell cultures were ini-
tiated by an explant technique, propagated at 37°C in 5% COZ
in enriched medium and subcultured repeatedly for several months
onto irradiated mouse 3T3 fibroblast feeder layers as described (23) .
The enriched epithelial culture medium consisted ofa 2:1(vol/vol)
mixture ofDMEM and Ham's F12 nutrient (Flow Laboratories,
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genetics, Milano, Italy), 0.4 NAg/ml hydrocortisone (Sigma Chem-
ical Co ., St . Louis, MO), 10 ng/mlrecombinanthuman epidermal
growth factor (EGF ; a gift from Dr. M. De Luca), 10- '°M
cholera enterotoxin (Sigma Chemical Co .), 5,ug/ml insulin (Sigma
Chemical Co.), 1.8 x 10-4M adenine (Sigma Chemical Co .), 100
U/ml penicillin (Flow Laboratories), 100Ag/ml streptomycin (Flow
Laboratories), 5 wg/ml human transferrin (Sigma Chemical Co.),
2 x 10-9M 3,3,5 triiodo-L-thyronine sodium salt (Sigma Chem-
ical Co .) ; 4MM L-glutamine (Flow Laboratories) . TEC were har-
vested on the second to third passage in vitro .
Thymocytes were obtained from thymus tissue by teasing and
purified by centrifugation through Ficoll-Hypaque . When appro-
priate, thymocytes were activated with PHA-M (Gibco Laborato-
ries, Grand Island, NY) at 10 /ug/ml or with PMA (Sigma Chem-
ical Co .) at 0.5 ng/ml in the presence of 0.5 ttg/ml of antibodies
to CD3 or to CD28 . Cells were maintained in culture by adding
50 U/ml rII,2 (Cetus Corp ., Emeryville, CA).
Purified E-rosetting cells were isolated from peripheral blood
according to methods described previously (24), and they are re-
ferred to as TPBL . Long-term PHA-stimulated cell lines were ini-
tiated by addingPHA(Gibco Laboratories) at 10 p,g/ml to PBMC,
as described (25) .These cells were maintained in culture by adding
50 U/ml rIIL2 (Cetus Corp .) twice weekly. Expression of 10 .1.2
was tested weekly on these cells, up to 5 wk .
Purified B cells were obtained from human tonsils (26) . Platelets
were isolated from heparinized human blood after centrifugation
through Ficoll-Hypaque andwere identified by light scatter profile
usinga FacStar® cytofluorograph (Becton Dickinson&Co., Moun-
tain View, CA) . Primary cultures of human skin keratinocytes were
kindly provided by Dr. M. De Luca . Umbilical cord endothelial
cells at the second passage in vitro were obtained from Dr. E. Dejana.
mAb Production .
￿
Thetechniques formAb production have been
described previously (27) . Briefly, BALB/c mice were immunized
intraperitoneally at 7-d intervalswith 5 x 106 TEC harvested after
the second passage in culture and kept frozen until use . A mouse
was killed 4 d after the third injection, and spleen cells were fused
with P3X63Ag8U1 myeloma cells (P3U1) according to themethod
of Gefter et al . (28) . 12 d after fusion, the supernatant of each cul-
ture well was assayed by ELISA with alkaline phosphatase-rabbit
anti-mouse IgGand IgM antibodies (Zymed Laboratories, South
San Francisco, CA), using 4 x 104 cells per well . Positive cultures
were cloned in soft agar as described by Cofino et al . (29) . The
Ig fraction was purified from ascites by precipitation with 40%
ammonium sulphate followed by gel filtration through an Ultrogel
AcA34 column .
Antibodies .
￿
The following reagents were used : W6/32 (anti-
MHC class 1) was from Dakopatts (Glostrup, Denmark) ; CK248
(anti-CD28) (30) was the gift of Dr. A. Poggi (Istituto Nazionale
per la Ricerca sul Canceo, Genova, Italy) ; MAR206 (anti-T11-1)
(31) was the gift of Dr. A. Moretta (Istituto di Anatomia Umana
Normale, University ofGenova, Italy); mAbs anti-CD1, anti-CD3,
anti-CD4, and anti-CD8 were obtained from the American Type
Culture Collection (ATCC ; Rockville, MD) ; PTF-22 .1 (anti-MHC
class 1), BT-2 .9 (anti-MHC class II), andthemAb anti-CD31 were
produced in our laboratory ; AE1-AE3 (anti-human epithelial pan-
keratin) wasfrom Menarini Diagnostici (Firenze, Italy) ; VIM 13.2
(anti-human vimentin)was from Biomedicals Ltd . (Liverpool, En-
gland) ; anti-(3,-peptide rabbit antiserum (anti-(3, integrin chain)
and anti-a 3-peptide rabbit antiserum (anti-a3 integrin chain) were
kindly provided byDr. G . Tarone (Dipartimento di Genetica, Bi-
ologia e Chimica Medica, University of Torino) . The polyclonal
antisera to the (3, and 013 integrin subunits were prepared by im-
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munizing rabbits against synthetic peptides reproducing amino acid
sequences from the cytoplasmic domain of each subunit . The fol-
lowing peptides, obtained from Multiple Peptide System (San Diego,
CA, USA), were used : /3,, CTTVVNPKYEGK; a3, CRIQP-
SETERLTDDY. Peptides were coupled to hemocyanin with
glutaraldehyde (approximate peptide/carrier molar ratio of 50 :1),
and rabbits were injected with 500 Ftg of the conjugate in CFA .
Antibodies reacted specifically with the peptide sequence used for
immunization, as determined by ELISAon peptide-BSA conjugates.
The antibodies were specific for the appropriate subunit and did
notshow crossreaction with other integrin subunits as demonstrated
by immunoprecipitation assays on different cell lines (G . Tarone,
personal communication) . TS2/7 (anti-al integrin chain) (32) and
B5G10 (anti-«4 integrin chain) (33) were kindly provided by Dr.
M. E. Hemler (Dana-Farber Cancer Center, Boston, MA) ; lOG11
(anti-C12 integrin chain) (34) and GoH3 (anti-a6 integrin chain)
(35) were kindly provided by Dr. A. Sonnenberg (Central Labora-
tory of The Netherlands Red Cross Blood, Transfusion Service,
Amsterdam, The Netherlands) ; anti-as-peptide rabbit antiserum
(anti-acs integrin chain) (36) was kindly provided by Dr. E. Ruos-
lahti (La Jolla Cancer Research Foundation, La Jolla, CA); NKI-
M7 (anti-cav integrin chain) (37) was kindly provided byDr. C. G.
Figdor (The Netherlands Cancer Institute, Division ofImmunology,
Amsterdam, the Netherlands) .
Staining Procedures.
￿
Indirect immunofluorescence was carried
out using cell suspensions . Briefly, cells were suspended in 100 JAI
ofDMEM + 10% FCS and incubatedwith the appropriate dilu-
tion of each antibody for 30 min at 4°C in the presence of 100
p,g ofpurified human Ig. After rinsing twice, cells were incubated
for 30 min at 4°C in 70 p,l of the same buffer containing 2 Rg
of affinity purified FITC-labeled goat anti-mouse IgG heavy and
light chains (Cappel Laboratories, Turnhout, Belgium) or affinity
purified FITC-labeled goat anti-rabbit IgG heavy and light chains
(ICN ImmunoBiologicals, Costa Mesa, CA) . Aftertwowashings,
cells were analyzed with a FacStar® cytofluorograph (Becton Dick-
inson & Co .) and a Dialux fluorescence microscope (Leitz).
The peroxidase-antiperoxidase (PAP) and alkaline phosphatase-
antialkaline phosphatase (APAAP) techniques (38, 39) were used
for theimmunocytochemical localization of the 10 .1.2 antigenand
ofkeratins inTEC culture monolayers and human tissues . Cryostat
sections were puton gelatin-coated slides, air-dried, andincubated
with the 10 .1.2 mAb (undiluted culture supernatant) for 1 h at
room temperature . For theAPAAP staining, cells and tissues were
subsequently incubated with rabbit anti-mouse Ig antibodies fol-
lowedby AP-labeled mouse anti-rabbit Ig . AP activity was subse-
quently revealed by incubation with NaphtholAS-MX Phosphate
(Sigma Chemical Co .) . Peroxidase activity was revealed using di-
aminobenzidine tetrahydrochloride (DAB ; Sigma Chemical Co .)
as substrate. All of the antibodies were purchasedfrom Dakopatts .
TECTbymocyte RosetteAssay .
￿
Binding ofTEC to thymocytes
or to TPBL was determined as described (20) . Briefly, 2 x 106
thymocytes orTPBL and 2.5 x 10 5 TEC were admixed in plastic
tubes in 200 Rtl ofRPMI 1640 (Flow Laboratories) supplemented
with 5% FCS at 4°C, centrifuged for 5 min at 250g at 4°C, and
incubated for 20 min at 4°C. After gentle resuspension, samples
were analyzed by microscopy, and TEC binding three or more
thymocytes or TPBL were scored as positive. In each assay, 200
TEC were enumerated and each determination was performed in
duplicate . In experiments done using mAbs to inhibit TEC-
thymocyte binding, the antibodies were added to each tube in a
volume of 10 itl before addition ofTEC at the concentrations indi-
cated in Fig . 5 .
Immunoprecipitation . Surface-iodinated TEC (6 x 106 cells)were lysed with PBS, 0.5% NP-40 containing 1 P,g/ml aprotinin,
1 14g/ml leupeptin, 100,ug/ml PMSF, 0.02 Wg/ml soybean trypsin
inhibitor (Sigma Chemical Co.), and centrifuged to remove nuclei
and cell debris . The lysate was rotated overnight at 4°C with the
antibodies indicated in Results . After incubation with the primary
antibodies, immune complexes were recovered with Protein A-Seph-
arose (Pharmacia Fine Chemicals, Uppsala, Sweden) . To avoid
nonspecific adsorption, incubation with primary antibodies was
preceded by incubation of cell lysates with Protein A-Sepharose.
After washing, antigens were elutedby boilingwith an equal volume
of 4% NaDodS0 4 .
Biochemical Analyses.
￿
TEC were surface labeled with 'III using
lactoperoxidase as described (40) . SDS-PAGE was carried out in
slab gels in a discontinuous Tris buffer system (41) . Proteins were
recovered as described and iodinated with the chloramine T method
according to Greenwood et al . (42) . Peptic peptide maps were ob-
tained as described (43) . Briefly, the eluted chains were digested
with pepsin (1:50 enzyme-to-protein weight ratio, 18 h at 37°C
in 100 p,l formic acid/acetic, acid/water buffer [1:4:45, vol/vol/vol]) .
Two-dimensional peptide maps were obtained by a technique de-
scribed previously (43) .
Results
Isolation ofHuman TEC.
￿
Long-term cultures of human
TEC were derived by the method described in Materials and
Methods. TEC were harvested after the second passage, and
their epithelial nature was assessed by staining with a panel
of antibodies against markers ofhuman cells of different lin-
eage. As shown in Table 1, cultured TEC were negative for
vimentin and other markers ofthymic lymphoid cells, fibro-
blasts, and macrophages, but were positive for keratins, pro-
teins produced exclusively by epithelial cells.
Production ofmAbs to Surface Antigens ofCultured TEC.
￿
The
spleen of a mouseimmunized with cultured TEC was fused
with P3U1 myeloma cells . Hybridoma supernatants were
tested by an ELISA standard method for the presence of anti-
bodies to surface determinants of cultured TEC. Positive su-
pernatants were then tested by the samemethod on cultured
foreskin fibroblasts and 3T3 cells, and by indirect im-
munofluorescence on thymocytes and PBL . Hybridoma su-
pernatants that reacted only with TEC were cloned in soft
agar and injected intraperitoneally in mice for production of
mAbs. Among the antibodies obtained, 10.1.2 (IgG1 isotype)
stained strongly all cultured TEC, while being consistently
negative on freshly isolated thymocytes, PBL (both resting
and after short-term culture withPHA), platelets, andB cells
(Fig. 1) . This mAb was next tested on a panel of cell lines
and found positive on cells of epithelial origin (HeLa cells
and primary cultures of human skin keratinocytes) and on
an endothelial cell line .
Fig. 2 shows an immunofluorescence analysis of 10.1.2 mol-
ecule expression on cultured T cell lines . After initial stimu-
lation with PHA and culture with rIL2, the levels of 10.1.2
expression on PBL slowly increased with time . The mean
fluorescence intensity increased minimally after 2wk of acti-
vation . However, after 3-4wk ofculture, 10.1.2 was expressed
by 73% of the cultured cells, albeit with a low fluorescence
intensity. In contrast, the 10.1.2 molecule was not detected
on thymocytes even after 3-4 wk of culture .
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Viable cell suspensions were stained in a surface immunofluorescence assay
followed by FRCS® analysis . Antikeratin and antivimentin reagents were
used to stain fixed cytocentrifuge cell preparations .
Tissue Distribution of the Antigen Recognized by the 10.1.2
mAh The reactivity of 10.1.2 with TEC used for immuni-
zation was tested also by APAAP staining of TEC culture
monolayers. Virtually all of the TEC were stained by both
the immunofluorescent and the APAAP technique (Fig. 3
a), whereas granulocytes, monocytes, and bone marrow cells
failed to react with the 10.1.2 mAb. Thymocytes from both
prenatal and postnatal thymuses were also negative.
Six thymuses from subjects of different age (between the
22nd week of gestation and 6 mo after birth) were tested
for their reactivity with the 10.1.2 mAb using cryostat sec-
tions and the APAAP and PAP techniques . Only medullary
epithelial cells and epithelial cells in the outer layers of the
thymic corpuscles were positive (Fig. 3 b .) TEC in the cortex
were consistently negative, as well as thymocytes, macrophages,
and other hemic cells. Interlobular blood vessels and arterioles
and venules at the cortico-medullaryjunction, as well as blood
vessels in other tissues, were stained at the endothelial level ;
the endothelial localization of the 10.1.2 mAb was promi-
nent in the lymph node high endothelial venules (Fig. 3 c) .
We subsequently tested a variety ofhuman tissues (skin,
thyroid gland, lung, salivary glands, kidney, liver, bone
marrow, spleen, and lymph nodes) for their reactivity with
the 10 .1.2mAb . Epithelial cells of thelung, thyroid, and kidney
were positive . Of note was the reactivity of the superficial
and lateral aspects ofthe cells in the basal layer ofthe epidermis,
whereas the deep surface of the basal cells facing the base-
ment membrane was unstained (Fig. 3 d) . These data indi-
cate that the 10.1.2 mAb reacts with a surface molecule ex-
pressed on medullary TEC, certain epithelial cells, and the
endothelia .
The 10 .1.2 mAb inhibits the Binding of Thymocytes to Cul-
tured TEC. The involvement of the molecule recognized
by the 10.1.2 mAb in the thymocyteTEC interaction was
Table 1 . Phenotypic
Antibody
characterization ofCultured
Specificity
Human TEC
Percent
positive cells
AE1-AE3 Human epithelial
pan-keratin 95-100
PTF-22.1 MHC class I 95-100
BT-2.9 MHC class II 10
mAb anti-CD31 CD31 0
VIM 13 .2 Human vimentin 1-2
MAR206 CD2 0
mAb anti-CD1 CD1 0
mAb anti-CD3 CD3 0
mAb anti-CD4 CD4 0
mAb anti-CD8 CD8 01-0910fluorescence intensity
Figure 1 .
￿
Expression of 10.1 .2 on different cell types . Cells were stained
with the 10.1 .2mAbfollowed by FITC-labeled anti-mouse Ig antiserum.
TEC, keratinocytes, Hela,and endothelial cells express the 10 .1.2 antigen.
tested using an in vitro rosette inhibition assay. When in-
cubated with cultured TEC at 4°C, allogeneic thymorytes
and TPBL spontaneously bind to TEC (reference 44, and
our own data) . Under these conditions, up to 40% of the
TEC bind several lymphoid cells, forming rosettes that can
be easily enumerated under the microscope. In our experi-
ments, TEC were admixed with freshly isolated thymorytes
or TPBL at a 1:10 ratio in the presence of different concen-
trations of 10.1.2, W6/32 (anti-MHC class I), andMAR206
(anti-CD2) mAbs. The latter represented a positive control,
as it has been shown that anti-CD2 antibodies inhibit this
type of rosette by interfering with the CD2/LFA3 interac-
tion (20) . In Fig. 4, weshow that rosette formation between
thymorytes andTEC is inhibited more effectively by the 10 .1.2
mAb than by anti-CD2 . However, this higher rate ofinhibi-
tion is not necessarily significant, because the extent of inhi-
bition by anti-CD2 antibodies depends on the type ofmAb
used, probably reflecting differences in affinity and/or epi-
tope specificity (20) . The same results in the rosette inhibi-
tion assay were obtainedwhen resting thymorytes were sub-
stituted for by thymorytes activated by incubation with
anti-CD3 or anti-CD28 antibodies that displayed a mature
phenotype (CD3+, CD4+CD8 - , or CD4 -CD8+) . By con-
trast, the interaction betweenTPBL and TEC was not affected
by the 10.1.2 mAb under experimental conditions in which
the anti-CD2 mAb yielded 40% inhibition of rosette for-
mation .
Biochemical Characterization of the Molecule Recognized by
the 10.1.2 mAb . Culture TEC were surface labeled with
125h lysed in PBS 0.5% NP-40, and the lysate was immu-
noprecipitated with 10.1.2 . Fig . 5 shows the electrophoretic
pattern obtained when the immunoprecipitate was analyzed
in SDS-PAGE . Under nonreducing conditions, two bands
were present with an apparent molecular mass of 150-160
and 110-120M Under reducing conditions, a single band
FRESHLY
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Thymocytes PBL
Log tofluorescence intensity
Figure 2.
￿
Expression of the 10 .1.2 molecule on cells in long-term cul-
ture. Thymocytes or PBLwere maintained in culture with rI1T2 after ini-
tial stimulation with PHA. Cells were stained with the 10.1 .2 mAb fol-
lowed by FITC-labeled goat anti-mouse Ig antiserum as described in
Materials andMethods. PBL, but not thymorytes, express the 10.1.2 de-
terminant after long-term culture .
with an apparent molecular mass of 130 kD was visible . Ex-
periments in which the two bands were eluted from a non-
reducing gel, and run again in SDS-PAGE after reduction
with mercaptoethanol, showed that the single band observed
under reducing conditions was indeed composed by the
150-160- and 110-120-kD bands, which, upon reduction,
comigrate with a nearly identical molecular mass (data not
shown) .
The 10.1.2 Molecule Is aMember ofthe Integrin Family.
￿
The
involvement of the molecule recognized by the 10.1.2 mAb
in the thymoryee-TEC interaction suggests that it may func-
tion as an adhesion molecule . Among the several groups of
adhesion molecules so far characterized, only a subset of the
integrin family, namely the very late antigens (VLAs), have
a subunit composition similar to that of the 10.1.2 molecule.
This set consists of several related molecules, many of them
sharing the same 110-kD (R1) chain, noncovalently linked
to a variety of cx chains ranging in molecular mass from 140
to 200 kD (45-49) . The 0, chain of the VLAs was consid-
ered a good candidate because in SDS-PAGE it behaves ex-
actly as the 110-120-kD band ofthe 10.1.2 molecule and mi-
grates to a position corresponding to 130kD upon reduction
(Fig . 5) . Sequential immunoprecipitation was then carried
out from a lysate ofTEC surface labeled with 1251 . The ly-
sate was precleared three times with an anti-R1 antiserum
and subsequently immunoprecipitated with 10.1.2 . Fig . 6
shows a SDS-PAGE analysis of the material immunoprecipi-
tated by 10.1.2 before and after preclearing with the anti -R1
antiserum or with an unrelated antiserum (anti-rc Ig chain) .1541
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￿
Incubation with the 10 .1 .2 mAb inhibits rosette formation
between TEC and thymocytes (a) but not betweenTEC andTPBL (b) .
Two additionalmAb were used aspositive and negative controls :MAR206
(anti-CD2) and W6/32 (anti-MHC class 1) . Each mAb was present in
each sample during the assay at the concentrations indicated (sup . is the
10 .1 .2 hybridoma cells supernatant) . The results are the mean of three
experiments using resting thymocytes .
Only a very faint band is visible after preclearing with the
anti -01 antiserum, suggesting that the molecule recognized
by the 10.1.2 mAb contains the 01 chain . In Fig . 6, a third
band with an apparent molecular mass of 83 kD is visible
in the profile obtained with both the 10.1.2 antibody and
the anti-01 antiserum . This band, which is sometimes
prominent inSDS-PAGE patterns ofintegrin molecules (see
Figs . 9 and 10 b), has been previously identified as a fragment
of a subunits (33, 50) . To confirm that 01 and the 110-kD
band present in the molecule recognized by the 10.1.2 mAb
Figure 5 .
￿
SDS-PAGE analysis of the protein precipitated from
1251_
labeled cultured TEC by the 10.1 .2 mAb and by an anti-01 antiserum .
After immunoprecipitation, samples were run in a6% polyacrylamide gel
under reducing (right) and nonreducing (left) conditions.
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Figure 6 .
￿
A comparison ofthe 10 .1.2 protein and the 01 VLAsubunit
under noureducing conditions in a6% polyacrylamide gel. The lysate of
1251 surface-labeled TEC was precleared three times with an anti-01 an-
tiserum or with a control antiserum (anti-ic Igchain), and immunoprecip-
itated with the 10 .1.2 mAb. From left to right: anti-human Ig K chain,
anti-ß1, 10 .1 .2, 10.1.2 after preclearing with anti-01, 10.1 .2 after
preclearing with anti-human Ig K chain .
were indeed identical, the two bands were eluted from the
gel, iodinated in SDS with Chloramine T (see Materials and
Methods), digested with pepsin in the presence of equal
amounts of a carrier protein (BSA) to ensure an identical en-
zyme to protein ratio (1:50), and their peptic peptide pat-
terns were compared by two-dimensional microfingerprinting
on silica gel plates (see Materials and Methods) . Fig . 7 shows
that the two patterns are nearly identical with most of the
peptides superimposable. Minor differences observed are likely
related to small amounts of contaminant proteins or to the
inherent power ofthe technique that separates peptides iden-
tical but in slightly different states of oxidation, thus enhancing
differences (51) . Taken together, these results indicate that
the t.ß1 chain and the 110-120-kD chain present in the mol-
ecule recognized by the 10.1.2 mAb are the product of the
same gene, even though the possibility that the two poly-
peptide chains are the result of an alternative splicing, which
seems to occur in this family of proteins, cannot be ruled
out on the basis of the available data .
The 150-160-hD Chain ofthe 10.1.2 Molecule Is Not Identifiable
as any ofthe Characterized Integrin a Chains. Seven different
01 subunit-associated ct chains have been characterized so
far : C11, a2, CO, Q(4, «5, CY6, and civ (48, 49), some of which
comigrate with 01 upon reduction . It is clear from Fig. 5
that the anti-N1 antiserum precipitates a mixture of integrins
with several differenta chains, some ofwhich do not change
behavior in SDS-PAGE under reducing conditions, whereas
the 10.1.2 mAb reacts with a single molecule, as indicated1543
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￿
A comparison of 10 .1.2
and ab proteins immunoprecipitated
from 1251-labeled TEC. TEC lysates
were immunoprecipitated using the
10.1 .2 mAb or the GoH3 mAb,
specific for theVLA ab chain . Sam-
ples were analyzed in6% SDS-PAGE
under nonreducing conditions.
by the sharper and fainter a chain band that, upon reduc-
tion, comigrates with /31 . The 10.1.2 mAb must then be
directed against the a subunit . The identity of the 150-160-
kD chain precipitated by the 10.1.2 mAb with three of the
knowna chains couldbe ruled out on the basis oftheir migra-
tion in SDS-PAGE . Thus, a1 migrates in SDS-PAGE as a
band of 200M which under reducing conditions appears
as a protein band of 210 kD. Moreover, an anti-a1 antibody
(TS2/7)was unable to precipitate any band from surface-labeled
TEC. The electrophoretic pattern obtained with the mAb
GoH3, which is specific for ab, shows several bands, none
Figure 9 .
￿
A comparison of 10 .1.2
and a, proteins immunoprecipitated
from 1251-labeled TEC. TEC lysates
were immunoprecipitated using the
10 .1 .2 mAb or the NKI-M7 mAb,
specific for the VLA a chain .
Samples were analyzed in 6% SDS-
PAGE under nonreducing conditions.
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Figure 10 .
￿
A comparison of 10 .1.2a subunit and the a2, 013, a5 inte-
grin chains. (a)A lysate of 1251 surface-labeled TEC was precleared repeat-
edly with the 10 .1.2mAb. The precleared lysate was divided into aliquots.
Each aliquot wasimmunoprecipitatedwith oneof the following antibodies:
10G11 mAb (anti-a2 integrin chain), anti-a3 peptide rabbit antiserum
(anti-a3 integrin chain), anti-a5 peptide rabbit antiserum (anti-as inte-
grin chain) . For abetter comparison, an aliquot of 10.1.2 imrttunoprecipi-
tated from the original lysate was loaded on the gel every two lanes . An
anti-CD4 antibody was used as control. The material precipitated by the
10.1 .2 mAb after the third preclearing was loaded in the last lane to the
right . (b) From left to right : material immunoprecipitated from a lysate
of 125 1 surface labeled TEC with the anti-a2, anti-as, and 10 .1.2 antibodies
without preclearing ; material immunoprecipitated by an anti-as antiserum
after three rounds of preclearing with 10 .1.2 ; material immunoprecipi-
rated by 10 .1.2 after three rounds ofpreclearing with anti-as or anti-«2 .
Samples were analyzed in6% SDS-PAGE under nonreducing conditions.
of which corresponds to the two bands precipitated by the
10.1.2 mAb (Fig. 8) . The a  chain could also be ruled out
since it is associated with a /3 chain of a molecular mass lower
than that of the 0 1 chain and compatible with that of 02
or /35 (Fig. 9) . The 014 chain was also ruled out because it
is not expressed byTEC (data not shown) . For the remainingas
10.1.2
a 2
T-PBL PLATELETS
Avm"
Log10fluorescence intensity
Figure 11 .
￿
Pattern of expression of VLA-5, 10.1.2, and VLA-2 on
TPBL and platelets . Cells were stained with an anti-as-peptide rabbit an-
tiserum, the 10 .1.2 mAb, and the 1OG11 (anti-a2 integrin chain) antibody
followed by FITC-labeled goat anti-mouse or anti-rabbit Ig antiserum
as described in Materials and Methods .
a chains, sequential immunoprecipitation was carried out from
surface-labeled TEC . Cell lysates were precleared three times
with 10.1.2 and then immunoprecipitated with antibodies
directed against the various a chains . As shown in Fig. 10
a, the anti-a2, anti-a3, and anti-as antibodies were capable
ofprecipitating bands corresponding to the molecule against
which they are directed, even after extensive preclearing with
10.1.2 . However, the level ofradiolabeled bands obtained with
anti-as and anti-a2 antibodies was rather low. Therefore, an-
other lysate was immunoprecipitated with anti-a2, anti-a5,
and 10.1.2 to assess the amount of each individual integrin
before preclearing . As shown in Fig. 10 b, the amount of
radioactivity precipitated by the anti-a5 antiserum is indeed
very low even before preclearing, and is not much reduced
after three rounds of preclearing with the 10.1.2 antibody.
When the preclearing was performed with anti-a2 or anti-
as, the intensity of the bands immunoprecipitated by the
10.1.2 antibody was again only slightly reduced. Moreover,
the molecular mass of the a2 subunit is higher than that of
the 10.1.2 a subunit (see Figs . 10, a and b) . The a5 band
is heavier than the 10.1.2 a subunit and has a smeared ap-
pearance, suggesting heterogeneity in its carbohydrate moiety .
As shown in Fig. 11, the pattern ofexpression of the three
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integrins VLA-2, VLA5, and 10.1.2 on TPBL and platelets
is also different . Thus, 10.1.2 is absent from both TPBL and
platelets, VLA-2 is present on platelets only, and VLA-5 is
present on both TPBL and platelets . Similar findings have
already been reported for the distribution of VLA2 and
VLA5, although the profile obtained with a mAb on platelets
indicated a more homogeneous distribution ofVLA5 (49)
than that revealed by the polyclonal antiserum used in our
study.
Therefore, we conclude that the 10.1.2 mAb is directed
against an integrin a chain that does not correspond to any
of the integrin a chains characterized so far .
Discussion
The determinant recognized by the mAb 10.1.2 belongs
to a surface molecule expressed by medullary TEC, which
is involved in the adhesion between thymocytes and TEC .
Other TEC receptors participating in this interaction have
already been described, and their ligands on thymocytes
identified . Thus, the CD2/LFA3 ligand pair has beenshown
to participate in the interaction between TEC and thymo-
cytes, either resting or activated (20, 21), whereas the LFA
1/ICAMA system appears to be involved in the binding of
activated thymocytes only (22) . The 10.1.2 molecule is then
part ofan adhesion system of increasing complexity that stabi-
lizes the interaction between these two types of cells in the
thymus . It is ofnote that the binding between the two ligands
of each pair (CD2/LFA-3, LFA-1/ICAM-1, 10.1.2/? ) is not
strong enough to keep the two cells together, as indicated
by the finding that rosette formation can be blocked using
antibodies that interfere with one pair of ligands only (refer-
ence 20, and our own data) . CD2 and LFA1, along with
other adhesion molecules, are present also on the surface of
other cell types, for instance, mature T lymphocytes, where
they help stabilize a variety of cell-cell interactions (20, 52-57) .
It is therefore likely that different combinations of several
complementary ligands, none ofwhich can mediate a binding
strong enough to support a functional interaction between
two cells, are used to promote specific contacts between
different types of cells . In this respect, it is of note that the
ligand of 10.1.2 is present on both resting and activated thymo-
cytes, but is absent on TPBL . Thus, the 10.1.2 mAb, unlike
anti-CD2 antibodies, is unable to inhibit rosette formation
between TPBL and TEC . The absence of the 10.1.2 mole-
cule from corticalTEC also suggests the possibility ofdifferen-
tial binding mechanisms of thymocyte subpopulations to cor-
tical and medullaryTEC . On the other hand, this molecule
is also expressed by other epithelial and endothelial cells, where
it mediates presumably different types of binding, perhaps
in combination with other adhesion molecules.
As the molecule recognized by the 10.1.2 mAb appears
to be a cell-cell adhesion protein, the finding that it is amember
of the integrin receptor family is not surprising . Integrins
are a growing family of surface molecules consisting oftwo
chains, a and fl, involved in cell-cell and cell-extracellular
matrix interactions (45) . At least 11 different a chains and
six different0 chains, encoded by two families ofrelated genes,have been described so far, andthey associatein variouscom-
binations forming several subsets of heterodimeric receptors
with different specificity (49, 58) . The 10.1.2 molecule is com-
posedby the at chain typical of theVLA subset, originally
described on activated T lymphocytes after several weeks in
culture (59) . The 10.1.2 molecule is indeed expressed by T
cells afterlong-term culture . However, thea chain does not
correspond to any of those already described. Although this
latter conclusion relies mainly on depletion experiments, other
evidences point to the same direction : a2 migrates in SDS-
PAGE as a band of 160kD under nonreducing conditions
and as a band of 165 kD (and not 130 kD) under reducing
conditions, and is expressedby platelets (the 10.1.2mAb does
not stain platelets), where it represents one of the collagen
receptor subunits ; a5 is the fibronectin receptor on platelets
and is expressed by resting CD4+ T cells (which do not bear
the 10.1.2 molecule); ab not only shows different bands in
SDS-PAGE but is also part of the laminin receptor of the
platelets; oc,, has an electrophoretic behavior different from
that of 10.1.2 and is expressedon fibroblasts that are negative
for 10 .1 .2 .
Preliminary experiments in which the 10.1.2mAbwasused
to inhibit the adhesion of TEC to the culture dish and to
purified laminin failed to show any effect of the antibody,
even at high concentration (100 hg/ml), suggesting that this
integrin is primarily involved in cell-to-cell contact . This con-
tention is reinforced by the finding that the 10.1.2 molecule
is absent in thedeep aspect ofthebasal epidermal cells, which
faces thebasement membrane. Furthermore thefinding that
the molecule is not expressed by thymocytes, either resting
or activated, indicates that this receptor is not homotypic
but binds to an as yet unidentified ligand .
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